Guest guest Posted June 12, 2006 Report Share Posted June 12, 2006 seems like these people should have to pay all the ill for the suffering all these years. Thank you Sharon, > > > June 11, 2006 > > Please forward the following valuable information to all interested parties. > Ie. Physicians, Researchers, Attorneys, Mold Victims, Health Advocates, > Building Stakeholders and Regulatory Bodies. > > Are you aware of the Order, April 14, 2006, Sacramento, CA? It is an > issue changing significant finding that will remove ‘road blocks’ and allow > the medical understanding of mold induced illnesses to more readily move > forward. > The significance of this Ruling as it pertains to mold litigation is: > > The defense argument of " not plausible, improbable and junk science " has now > been determined by the courts to be " not plausible, improbable and junk > science " . > The Ruling is a huge blow to those who are most concerned about > perpetuating the litigation defense argument that serious mold illnesses do occur > from exposure within an indoor environment. The Ruling discredits the entire > foundation of All the medical associations, government documents, etc, that > illness from inhaling mycotoxins indoors is " not plausible, improbable and junk > science " . One could say those, who more concerned of financial liability > than they are of the lives and safety of others, just got a “fatal dose†of > their own medicine. > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > Case # 02AS04291, Harold and D. Lee Harold, Plaintiffs vs. California > Casualty Insurance Company and Westmont Construction, Inc., Defendants > > Honorable P. Kenny, Judge of the Superior Court of California, > County of Sacramento > The Plaintiffs were represented by Alfert, Attorney at Law; J. > Cochrane, Attorney at Law, and Kahn, Attorney at Law. > The Defendant, California Casualty Insurance Company, was represented by > M. , Attorney at Law, and S. McLay, Attorney at Law. > The Defendant, Westmont Construction Company, was represented by E. > Enabnit, Attorney at Law. > Jury award to plaintiffs: $2.3 Million. > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > Subject paper deemed not acceptable by Ruling, April 14, 2006 > > Title: Risk from inhaled mycotoxins in indoor office and residential > environments. Int J > Toxicol 2004; 23: 3-10. > Robbins CA, Swenson LJ, Hardin BD (Principals of litigation defense support > corp. > Veritox, Inc and formerly named GlobalTox, Inc.) > Slang: Veritox, 2004 > > The above is the review piece that was found not to be based upon sound > science and therefore not to be presented in the court before a jury. The judge > found it to be a " huge leap " , for PhD's to take rodent studies, apply a > little math and then write a review that all human illness is not plausible from > mycotoxin inhalation within an indoor environment. Dr. Robbins of Veritox, > Inc., could not cite anyone else's research or review paper that made the same > conclusion. > The reason for this is because there are not any. > > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > To understand why this is such a boon to move the medical science forward > and a huge blow to the defense in mold litigation, one has to go back to the > year 2000: > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~ > 2000 > Title: Health effects of mycotoxins in indoor air: a critical review. Appl > Occup Environ > Hyg.2000;15:773-84. > Robbins CA, Swenson, L.J., Nealley, M.L., Kelman, B.J. and Gots, R.E. > Slang: Veritox, 2000 > > Robbins, Swenson and Kelman - Principals in defense litigation support corp, > Veritox. > Nealley and Gots -Defense experts with International Center for Toxicology > and Medicine. > > Veritox 2000 is based on the same premise as the Veritox 2004 cited above. > Rodents, authors added math, human illness not plausible. > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > 2002 > The American College of Occupational and Environmental Medicine (ACOEM) Mold > Statement > Title: Adverse Human Health Effects Associated with Molds in the Indoor > Environment > October 27, 2002 > Kelman BJ (Veritox), Hardin BD (Veritox), Saxon AJ.(University of California > - UC) > Edited & published in the Journal of ACOEM, the JOEM 2003 > Slang: ACOEM MS, 2002 > > " Levels of exposure in the indoor environment, dose-response data in > animals, and dose-rate considerations suggest that delivery by the > inhalation route of a toxic dose of mycotoxins in the indoor environment is > highly unlikely at best, even for the hypothetically most vulnerable > subpopulations. " > > Sole reference for the above statement: > Veritox, 2000. Reference 63 > NONE of the other 83 references cited for this ‘state of the art review piece > ’ support the above conclusion. > ACOEM MS, 2002 was presented as a position statement purportedly > representative of 7000 physicians’ understanding of mold/mold toxin induced illness. > ACOEM is made up primarily of physicians who evaluate injured workers on > behalf of insurers and employers. > > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > 2003 > US Chamber/Manhattan Institute Mold Statement > Title: A Scientific View of the Health Effects of Mold > Hardin, PhD (Veritox), Saxon MD (UC), Correen Robbins, PhD, > CIH > (Veritox) and Bruce J. Kelman, Ph.D., DABT (Veritox) > Slang: USCC MS, 2003 > > “Thus the notion that ‘toxic mold’ is an insidious secret ‘killer’ as so > many > media reports and trial lawyers would claim is ‘Junk Science’ unsupported > by actual scientific study.†> Sole references for the above statement: > Veritox, 2000 and ACOEM MS 2002 > The USCC MS 2003 has been reported by the Veritox authors to be a " lay > translation " of the ACOEM Mold Statement. They were ‘commissioned’ by the > Manhattan Institute to write this lay translation and received $40,000 for this ‘ > commissioned lay translation’ of the ACOEM Mold Statement. It was then shared > with stakeholder industries (real estate, building, mortgage and insurance) > in a fanfare presentation in Washington, DC, July 17, 2003. > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > 2003 > National Association of Realtors (NAR) > Title: Moldy Claims: The Junk Science of Toxic Mold > Kelman BJ.(Veritox) Hardin BD.(Veritox) Saxon AJ.(UC) > Slang: NAR 2003 > > “Thus the notion that ‘toxic mold’ is an insidious secret ‘killer’ as so > many > media reports and trial lawyers would claim is ‘Junk Science’ unsupported > by actual scientific study.†> > Sole references for the above statement: > Veritox, 2000, ACOEM MS 2002 and USCC MS 2003. > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > 2004 > Title: Risk from inhaled mycotoxins in indoor office and residential > environments. Int J > Toxicol 2004; 23: 3-10. > Robbins CA, Swenson LJ, Hardin BD. (Veritox, Inc. Principals) > Slang: Veritox, 2004 > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > 2003 to 2005 > Various Government Regulatory (CDC & EPA), Medical Associations (ACAAI, > SOT), Industrial Hygeine Associations (AIHA), etc. make the findings of " not > plausible " citing Veritox 2000, ACOEM MS 2002, USCC MS 2003, NAR 2003 and/or > Veritox 2004. These five review papers have been cited as authoritative documents > by the defense in virtually every mold litigation case in the US. > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > 2006 > American Academy of Allergy, Asthma and Immunology (AAAAI) Mold Position > Title: The medical effects of mold exposure > Bush RK, Terr A.(UC), Saxon AJ (UC) and Wood RA. > Slang: Quad AI 2006 > > “Calculations for both acute and subacute exposures on the basis of the > maximum amount of mycotoxins found per mold spore for various > mycotoxins and the levels at which adverse health effects are observed > make it highly improbable that home or office mycotoxin exposures would > lead to a toxic adverse health effects.1, 29 > > Thus we agree with the American College of Occupational and > Environmental Medicine evidence-based statement and the Institute of > Medicine draft, which conclude that the evidence does not support the > contention that mycotoxin-mediated disease (mycotoxicosis) occurs > through inhalation in nonoccupational settings. " > > > Sole reference for the above statements: > ACOEM MS 2002 - Reference 1; Veritox 2004 - Reference 29. > > Note: Saxon (UC) is an author of ACOEM MS 2002, USCC 2003, NAR 2003, & Quad > AI > 2006 > Veritox principals are authors of Veritox 2000, ACOEM MS 2002, USCC 2003, > NAR > 2003 & Veritox 2004. > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > 2006 > Robbins Order, Ruling, April 14, 2006 > Veritox 2004 does not pass . > > Veritox 2004 is the ‘second generation’ of Veritox 2000. Both ‘review papers > ’ are founded on the same premise that is now debunked as not being of sound > scientific protocol to determine absence of human illness from mycotoxin > inhalation indoors. > > ACOEM MS 2002, USCC MS 2003, NAR MS 2003, and Quad AI MS 2006 are all > founded on the Veritox 2004 or Veritox 2000. > Statements of " not plausible, improbable, and junk science " within all > papers are debunked by the debunking of the Veritox 2004. > > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~ > Additional Information of Significance, 2006 > > The Institute of Medicine (IOM), Damp Indoor Spaces and Health Report, was a > primary exhibit in the hearing that discredited the Veritox 2004. > > IOM Chapter 4 Mycotoxins > Summary: > “Except for a few studies on cancer, toxicologic studies of mycotoxins are > acute or short-term studies that use high exposure concentrations to reveal > immediate effects in small populations of animals. Chronic studies that use > > lower exposure concentrations and approximate human exposure more > closely have not been done except for a small number of cancer studies.†> > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~ > 2006 > Minutes from the US Surgeon General's Workshop on Indoor Air are published > > " Dr. Noreen [Chair of the IOM Damp Indoor Spaces and Health Report, > 2004] indicated that the report did not consider only respiratory symptoms, but > that these were the symptoms for which associations were strongest. She > noted that " absence of evidence is not evidence of absence, " and said that the > report did not intend to dismiss the possibility of effects for which the > existing evidence of association was not strong or for which evidence was not > available. " > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > 2006 > > State of California Report in Response to A.B. 284, Chapter 550, Statutes > of 2001 > Indoor Mold: A General Guide to Health Effects, Prevention, and Remediation. > (CRB-06-001 , January 2006) > W. Umbach, Ph.D., and Pamela J. , R.N., P.H.N. > . > Page 72 " Some experts believe that the ACOEM statement understates risks and > effects. " > Page 75 " The question of whether health effects result from indoor exposure > to mycotoxins is controversial, as stated in the text and is noted above. > The conclusion in the present report that such effects are at least plausible > reflects, for example ... " There is an accumulated weight of evidence linking > indoor airborne mold and/or mycotoxin exposures to multisystem adverse human > health effects. " > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > 2006 > > Center for Science in the Public Interest > > Washington, DC > > Integrity in Science Watch -- Week of 3/31/2006 > Allergy Journal Authors Failed to Disclose Conflicts of Interest > The prestigious Journal of Allergy and Clinical Immunology (JACI) last month > failed to disclose two physicians' roles as insurance company defense > experts in their scientific review " The Medical Effects of Mold Exposure, " which > downplayed risks to human health from household mold. According to court > documents obtained by the Center for Science in the Public Interest, Dr. Abba I. > Terr, Stanford University School of Medicine, and Dr. Saxon, University > of California at Los Angeles School of Medicine, were paid up to $600 an hour > for testimony in cases brought by homeowners alleging their illnesses were > caused by mold. JACI, the journal of the American Academy of Allergy, Asthma > and Immunology (AAAAI), requires authors to disclose conflicts of interest to > the editor, who then has discretion in publishing them. In a letter to editor > Leung, CSPI urged AAAAI to make disclosure mandatory and prevent > authors who fail to disclose conflicts of interest from publishing in the journal > for three years. > Week of 4/24/06 > > Allergy Journal Strengthens Conflicts of Interest Disclosure Policy > The Journal of Allergy and Clinical Immunology (JACI), an Elsevier > publication, will require greater financial disclosure from authors and automatically > publish those disclosures, the editor said. Two mold experts, Dr. Abba Terr > and Dr. Saxon, failed to disclose their roles as defense witnesses in > mold exposure liability lawsuits when publishing a review in the journal > earlier this year that downplayed the risks from household mold exposure. Editor > Leung said future author conflict of interest forms accompanying JACI > submissions will now include " specific questions " about expert witnessing and > the journal will " ensure that all published manuscripts will carry a conflict > of interest statement regarding each author. " > Week of 6/5/06 > > Environmental Journal Retracts Fraudulent Study on Chromium > > [significance: Journal of ACOEM Retracts Fraudulent Study Authored by Expert > Defense Witnesses for Usage in Court] > The Journal of Occupational and Environmental Medicine [Journal of ACOEM] > will retract a 1997 article on chromium written under the names of two Chinese > scientists after a Wall Street Journal investigation revealed that the > article was actually drafted and edited by consultants for a major chromium > polluter. Chemrisk, founded and directed by Dennis Paustenbach (see > http://www.IntegrityinScience.org/), purchased in 1995 JianDong Zhang's original data on the > link between chromium-6 in drinking water and cancer in Chinese villages. > Chemrisk, which had been hired by Pacific Gas and Electric, the California > utility company being sued for chromium contamination, then reworked the data to > show that Zhang, who objected to the publication, had reversed his conclusion > on the chromium-cancer link The JOEM retraction, signed by editor Dr. > Brandt-Rauf, states that the article did not comply with the journal's policy > because " financial and intellectual input to the paper by outside parties was > not disclosed. " Since its publication, the fake article has influenced > regulatory decisions on chromium, including being used by a scientific panel for a > 2001 report which forced California health officials to revise a > recommendation for how much chromium-6 should be allowed in drinking water. > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > Summary > Many people have been ill with serious mold/mycotoxin induced illnesses. > They have been unable to obtain proper medical treatment prior to the time these > illnesses have become progressively and irreversibly debilitating. Many > physicians and citizens have been falsely told that mold does not cause serious > illness, leaving the medical community and public uneducated and unaware of > the true danger. > The medical misinformation promoted for the benefit of the defense in mold > litigation has stifled and confused the already young field of science. It has > fueled contention. The promotion of the concept " not plausible, improbable, > junk science " within the medical community and the general public has been a > primary cause for the lack of early detection and timely medical treatment. > This in turn, has cost stakeholders with financial interest in the moldy > buildings, unnecessary billions. The misinformation, that has retarded proper > medical understanding, has also caused a tremendous increase in financial > responsibility for stakeholders. Increased health damages sustained equals > increased resultant stakeholder liability. . > > Mold itself, has not been the crux of the problem. The denial of illness in > an attempt to limit liability has directly caused greater illness - and > thereby has caused greater liability. The situation has been wastefully self > perpetuating. The defense argument of “not plausible, improbable and junk science†> has proven to be its own worst enemy. > > Dr Borak, overseer for the " peer review process " of the ACOEM Mold > Statement, summed the matter up best in an email he wrote in 2002: > > Email September 8, 2002 > From: Borak, Chair of the Scientific Committee, ACOEM > Dean Grove, Past President, ACOEM > CC: Bernacki, ACOEM President 2002; Barry Eisenberg, > Executive Director ACOEM; Tim Key, ACOEM President 2003. > > " Dean et al: > > I am having quite a challenge in finding an acceptable path for the > proposed position paper on mold. Even though a great deal of work has > gone in, it seems difficult to satisfy a sufficient spectrum of the College, > or > at least those concerned enough to voice their views. > > I have received several sets of comments that find the current version, > much revised, to still be a defense argument. On the other hand, > Hardin and his colleagues are not willing to further dilute the paper. The > have done a lot, and I am concerned that we will soon have to either > endorse or let go. I do not want to go to the BOD and then be rejected. > That would be an important violation of . I have assured him that if > we do not use it he can freely make whatever other uses he might want to > make. If we " officially " reject it, then we turn is efforts into garbage. > .... " > > Garbage it was, based on the Veritox 2000 ‘review’ and provided credibility > by the imprimatur of ACOEM. Once the credibility was established by the > ACOEM, the garbage was then spread to other purported state of the art, mold > review papers. > The unscientific concept that one could take a single review of rodent > studies with math applied and determine all human illness from inhaling mycotoxins > indoors could never happen, took on a life of its own and grew. It became > understood that one could never become seriously ill from inhaling mold > indoors. > No one seemed to remember exactly how this concept came to be. They just > knew it to be true because they had read it in many authoritative " state of the > art " mold review papers. > The lives, health and financial well being of thousands have been forever > damaged because of it. > > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > And that is the Landmark Significance of the Ruling on April 14, > 2006, Sacramento, California, regarding " Risk from inhaled mycotoxins in indoor > office and residential environments. Int J Toxicol 2004; 23: 3- 10.Robbins CA, > Swenson LJ, Hardin BD. (Veritox, 2004). The courts have found Veritox 2004 is > not plausible, improbable and Junk Science. > > Needless to say, I am thrilled. Maybe NOW we can get this issue out of the > courts and into doctors’ offices where it belongs. Maybe NOW we can all stop > wasting time, lives and money! > > Sharon Kramer > 760-822-8026 > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 12, 2006 Report Share Posted June 12, 2006 WOOHOO, Thanks Sharon, about time they threw that junk science where it belongs, in the trash. should be a class action from all the victoms that lost theri case because of that trash and got nada zilch. > > > June 11, 2006 > > Please forward the following valuable information to all interested parties. > Ie. Physicians, Researchers, Attorneys, Mold Victims, Health Advocates, > Building Stakeholders and Regulatory Bodies. > > Are you aware of the Order, April 14, 2006, Sacramento, CA? It is an > issue changing significant finding that will remove ‘road blocks’ and allow > the medical understanding of mold induced illnesses to more readily move > forward. > The significance of this Ruling as it pertains to mold litigation is: > > The defense argument of " not plausible, improbable and junk science " has now > been determined by the courts to be " not plausible, improbable and junk > science " . > The Ruling is a huge blow to those who are most concerned about > perpetuating the litigation defense argument that serious mold illnesses do occur > from exposure within an indoor environment. The Ruling discredits the entire > foundation of All the medical associations, government documents, etc, that > illness from inhaling mycotoxins indoors is " not plausible, improbable and junk > science " . One could say those, who more concerned of financial liability > than they are of the lives and safety of others, just got a “fatal dose†of > their own medicine. > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > Case # 02AS04291, Harold and D. Lee Harold, Plaintiffs vs. California > Casualty Insurance Company and Westmont Construction, Inc., Defendants > > Honorable P. Kenny, Judge of the Superior Court of California, > County of Sacramento > The Plaintiffs were represented by Alfert, Attorney at Law; J. > Cochrane, Attorney at Law, and Kahn, Attorney at Law. > The Defendant, California Casualty Insurance Company, was represented by > M. , Attorney at Law, and S. McLay, Attorney at Law. > The Defendant, Westmont Construction Company, was represented by E. > Enabnit, Attorney at Law. > Jury award to plaintiffs: $2.3 Million. > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > Subject paper deemed not acceptable by Ruling, April 14, 2006 > > Title: Risk from inhaled mycotoxins in indoor office and residential > environments. Int J > Toxicol 2004; 23: 3-10. > Robbins CA, Swenson LJ, Hardin BD (Principals of litigation defense support > corp. > Veritox, Inc and formerly named GlobalTox, Inc.) > Slang: Veritox, 2004 > > The above is the review piece that was found not to be based upon sound > science and therefore not to be presented in the court before a jury. The judge > found it to be a " huge leap " , for PhD's to take rodent studies, apply a > little math and then write a review that all human illness is not plausible from > mycotoxin inhalation within an indoor environment. Dr. Robbins of Veritox, > Inc., could not cite anyone else's research or review paper that made the same > conclusion. > The reason for this is because there are not any. > > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > To understand why this is such a boon to move the medical science forward > and a huge blow to the defense in mold litigation, one has to go back to the > year 2000: > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~ > 2000 > Title: Health effects of mycotoxins in indoor air: a critical review. Appl > Occup Environ > Hyg.2000;15:773-84. > Robbins CA, Swenson, L.J., Nealley, M.L., Kelman, B.J. and Gots, R.E. > Slang: Veritox, 2000 > > Robbins, Swenson and Kelman - Principals in defense litigation support corp, > Veritox. > Nealley and Gots -Defense experts with International Center for Toxicology > and Medicine. > > Veritox 2000 is based on the same premise as the Veritox 2004 cited above. > Rodents, authors added math, human illness not plausible. > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > 2002 > The American College of Occupational and Environmental Medicine (ACOEM) Mold > Statement > Title: Adverse Human Health Effects Associated with Molds in the Indoor > Environment > October 27, 2002 > Kelman BJ (Veritox), Hardin BD (Veritox), Saxon AJ.(University of California > - UC) > Edited & published in the Journal of ACOEM, the JOEM 2003 > Slang: ACOEM MS, 2002 > > " Levels of exposure in the indoor environment, dose-response data in > animals, and dose-rate considerations suggest that delivery by the > inhalation route of a toxic dose of mycotoxins in the indoor environment is > highly unlikely at best, even for the hypothetically most vulnerable > subpopulations. " > > Sole reference for the above statement: > Veritox, 2000. Reference 63 > NONE of the other 83 references cited for this ‘state of the art review piece > ’ support the above conclusion. > ACOEM MS, 2002 was presented as a position statement purportedly > representative of 7000 physicians’ understanding of mold/mold toxin induced illness. > ACOEM is made up primarily of physicians who evaluate injured workers on > behalf of insurers and employers. > > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > 2003 > US Chamber/Manhattan Institute Mold Statement > Title: A Scientific View of the Health Effects of Mold > Hardin, PhD (Veritox), Saxon MD (UC), Correen Robbins, PhD, > CIH > (Veritox) and Bruce J. Kelman, Ph.D., DABT (Veritox) > Slang: USCC MS, 2003 > > “Thus the notion that ‘toxic mold’ is an insidious secret ‘killer’ as so > many > media reports and trial lawyers would claim is ‘Junk Science’ unsupported > by actual scientific study.†> Sole references for the above statement: > Veritox, 2000 and ACOEM MS 2002 > The USCC MS 2003 has been reported by the Veritox authors to be a " lay > translation " of the ACOEM Mold Statement. They were ‘commissioned’ by the > Manhattan Institute to write this lay translation and received $40,000 for this ‘ > commissioned lay translation’ of the ACOEM Mold Statement. It was then shared > with stakeholder industries (real estate, building, mortgage and insurance) > in a fanfare presentation in Washington, DC, July 17, 2003. > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > 2003 > National Association of Realtors (NAR) > Title: Moldy Claims: The Junk Science of Toxic Mold > Kelman BJ.(Veritox) Hardin BD.(Veritox) Saxon AJ.(UC) > Slang: NAR 2003 > > “Thus the notion that ‘toxic mold’ is an insidious secret ‘killer’ as so > many > media reports and trial lawyers would claim is ‘Junk Science’ unsupported > by actual scientific study.†> > Sole references for the above statement: > Veritox, 2000, ACOEM MS 2002 and USCC MS 2003. > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > 2004 > Title: Risk from inhaled mycotoxins in indoor office and residential > environments. Int J > Toxicol 2004; 23: 3-10. > Robbins CA, Swenson LJ, Hardin BD. (Veritox, Inc. Principals) > Slang: Veritox, 2004 > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > 2003 to 2005 > Various Government Regulatory (CDC & EPA), Medical Associations (ACAAI, > SOT), Industrial Hygeine Associations (AIHA), etc. make the findings of " not > plausible " citing Veritox 2000, ACOEM MS 2002, USCC MS 2003, NAR 2003 and/or > Veritox 2004. These five review papers have been cited as authoritative documents > by the defense in virtually every mold litigation case in the US. > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > 2006 > American Academy of Allergy, Asthma and Immunology (AAAAI) Mold Position > Title: The medical effects of mold exposure > Bush RK, Terr A.(UC), Saxon AJ (UC) and Wood RA. > Slang: Quad AI 2006 > > “Calculations for both acute and subacute exposures on the basis of the > maximum amount of mycotoxins found per mold spore for various > mycotoxins and the levels at which adverse health effects are observed > make it highly improbable that home or office mycotoxin exposures would > lead to a toxic adverse health effects.1, 29 > > Thus we agree with the American College of Occupational and > Environmental Medicine evidence-based statement and the Institute of > Medicine draft, which conclude that the evidence does not support the > contention that mycotoxin-mediated disease (mycotoxicosis) occurs > through inhalation in nonoccupational settings. " > > > Sole reference for the above statements: > ACOEM MS 2002 - Reference 1; Veritox 2004 - Reference 29. > > Note: Saxon (UC) is an author of ACOEM MS 2002, USCC 2003, NAR 2003, & Quad > AI > 2006 > Veritox principals are authors of Veritox 2000, ACOEM MS 2002, USCC 2003, > NAR > 2003 & Veritox 2004. > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > 2006 > Robbins Order, Ruling, April 14, 2006 > Veritox 2004 does not pass . > > Veritox 2004 is the ‘second generation’ of Veritox 2000. Both ‘review papers > ’ are founded on the same premise that is now debunked as not being of sound > scientific protocol to determine absence of human illness from mycotoxin > inhalation indoors. > > ACOEM MS 2002, USCC MS 2003, NAR MS 2003, and Quad AI MS 2006 are all > founded on the Veritox 2004 or Veritox 2000. > Statements of " not plausible, improbable, and junk science " within all > papers are debunked by the debunking of the Veritox 2004. > > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~ > Additional Information of Significance, 2006 > > The Institute of Medicine (IOM), Damp Indoor Spaces and Health Report, was a > primary exhibit in the hearing that discredited the Veritox 2004. > > IOM Chapter 4 Mycotoxins > Summary: > “Except for a few studies on cancer, toxicologic studies of mycotoxins are > acute or short-term studies that use high exposure concentrations to reveal > immediate effects in small populations of animals. Chronic studies that use > > lower exposure concentrations and approximate human exposure more > closely have not been done except for a small number of cancer studies.†> > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~ > 2006 > Minutes from the US Surgeon General's Workshop on Indoor Air are published > > " Dr. Noreen [Chair of the IOM Damp Indoor Spaces and Health Report, > 2004] indicated that the report did not consider only respiratory symptoms, but > that these were the symptoms for which associations were strongest. She > noted that " absence of evidence is not evidence of absence, " and said that the > report did not intend to dismiss the possibility of effects for which the > existing evidence of association was not strong or for which evidence was not > available. " > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > 2006 > > State of California Report in Response to A.B. 284, Chapter 550, Statutes > of 2001 > Indoor Mold: A General Guide to Health Effects, Prevention, and Remediation. > (CRB-06-001 , January 2006) > W. Umbach, Ph.D., and Pamela J. , R.N., P.H.N. > . > Page 72 " Some experts believe that the ACOEM statement understates risks and > effects. " > Page 75 " The question of whether health effects result from indoor exposure > to mycotoxins is controversial, as stated in the text and is noted above. > The conclusion in the present report that such effects are at least plausible > reflects, for example ... " There is an accumulated weight of evidence linking > indoor airborne mold and/or mycotoxin exposures to multisystem adverse human > health effects. " > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > 2006 > > Center for Science in the Public Interest > > Washington, DC > > Integrity in Science Watch -- Week of 3/31/2006 > Allergy Journal Authors Failed to Disclose Conflicts of Interest > The prestigious Journal of Allergy and Clinical Immunology (JACI) last month > failed to disclose two physicians' roles as insurance company defense > experts in their scientific review " The Medical Effects of Mold Exposure, " which > downplayed risks to human health from household mold. According to court > documents obtained by the Center for Science in the Public Interest, Dr. Abba I. > Terr, Stanford University School of Medicine, and Dr. Saxon, University > of California at Los Angeles School of Medicine, were paid up to $600 an hour > for testimony in cases brought by homeowners alleging their illnesses were > caused by mold. JACI, the journal of the American Academy of Allergy, Asthma > and Immunology (AAAAI), requires authors to disclose conflicts of interest to > the editor, who then has discretion in publishing them. In a letter to editor > Leung, CSPI urged AAAAI to make disclosure mandatory and prevent > authors who fail to disclose conflicts of interest from publishing in the journal > for three years. > Week of 4/24/06 > > Allergy Journal Strengthens Conflicts of Interest Disclosure Policy > The Journal of Allergy and Clinical Immunology (JACI), an Elsevier > publication, will require greater financial disclosure from authors and automatically > publish those disclosures, the editor said. Two mold experts, Dr. Abba Terr > and Dr. Saxon, failed to disclose their roles as defense witnesses in > mold exposure liability lawsuits when publishing a review in the journal > earlier this year that downplayed the risks from household mold exposure. Editor > Leung said future author conflict of interest forms accompanying JACI > submissions will now include " specific questions " about expert witnessing and > the journal will " ensure that all published manuscripts will carry a conflict > of interest statement regarding each author. " > Week of 6/5/06 > > Environmental Journal Retracts Fraudulent Study on Chromium > > [significance: Journal of ACOEM Retracts Fraudulent Study Authored by Expert > Defense Witnesses for Usage in Court] > The Journal of Occupational and Environmental Medicine [Journal of ACOEM] > will retract a 1997 article on chromium written under the names of two Chinese > scientists after a Wall Street Journal investigation revealed that the > article was actually drafted and edited by consultants for a major chromium > polluter. Chemrisk, founded and directed by Dennis Paustenbach (see > http://www.IntegrityinScience.org/), purchased in 1995 JianDong Zhang's original data on the > link between chromium-6 in drinking water and cancer in Chinese villages. > Chemrisk, which had been hired by Pacific Gas and Electric, the California > utility company being sued for chromium contamination, then reworked the data to > show that Zhang, who objected to the publication, had reversed his conclusion > on the chromium-cancer link The JOEM retraction, signed by editor Dr. > Brandt-Rauf, states that the article did not comply with the journal's policy > because " financial and intellectual input to the paper by outside parties was > not disclosed. " Since its publication, the fake article has influenced > regulatory decisions on chromium, including being used by a scientific panel for a > 2001 report which forced California health officials to revise a > recommendation for how much chromium-6 should be allowed in drinking water. > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > Summary > Many people have been ill with serious mold/mycotoxin induced illnesses. > They have been unable to obtain proper medical treatment prior to the time these > illnesses have become progressively and irreversibly debilitating. Many > physicians and citizens have been falsely told that mold does not cause serious > illness, leaving the medical community and public uneducated and unaware of > the true danger. > The medical misinformation promoted for the benefit of the defense in mold > litigation has stifled and confused the already young field of science. It has > fueled contention. The promotion of the concept " not plausible, improbable, > junk science " within the medical community and the general public has been a > primary cause for the lack of early detection and timely medical treatment. > This in turn, has cost stakeholders with financial interest in the moldy > buildings, unnecessary billions. The misinformation, that has retarded proper > medical understanding, has also caused a tremendous increase in financial > responsibility for stakeholders. Increased health damages sustained equals > increased resultant stakeholder liability. . > > Mold itself, has not been the crux of the problem. The denial of illness in > an attempt to limit liability has directly caused greater illness - and > thereby has caused greater liability. The situation has been wastefully self > perpetuating. The defense argument of “not plausible, improbable and junk science†> has proven to be its own worst enemy. > > Dr Borak, overseer for the " peer review process " of the ACOEM Mold > Statement, summed the matter up best in an email he wrote in 2002: > > Email September 8, 2002 > From: Borak, Chair of the Scientific Committee, ACOEM > Dean Grove, Past President, ACOEM > CC: Bernacki, ACOEM President 2002; Barry Eisenberg, > Executive Director ACOEM; Tim Key, ACOEM President 2003. > > " Dean et al: > > I am having quite a challenge in finding an acceptable path for the > proposed position paper on mold. Even though a great deal of work has > gone in, it seems difficult to satisfy a sufficient spectrum of the College, > or > at least those concerned enough to voice their views. > > I have received several sets of comments that find the current version, > much revised, to still be a defense argument. On the other hand, > Hardin and his colleagues are not willing to further dilute the paper. The > have done a lot, and I am concerned that we will soon have to either > endorse or let go. I do not want to go to the BOD and then be rejected. > That would be an important violation of . I have assured him that if > we do not use it he can freely make whatever other uses he might want to > make. If we " officially " reject it, then we turn is efforts into garbage. > .... " > > Garbage it was, based on the Veritox 2000 ‘review’ and provided credibility > by the imprimatur of ACOEM. Once the credibility was established by the > ACOEM, the garbage was then spread to other purported state of the art, mold > review papers. > The unscientific concept that one could take a single review of rodent > studies with math applied and determine all human illness from inhaling mycotoxins > indoors could never happen, took on a life of its own and grew. It became > understood that one could never become seriously ill from inhaling mold > indoors. > No one seemed to remember exactly how this concept came to be. They just > knew it to be true because they had read it in many authoritative " state of the > art " mold review papers. > The lives, health and financial well being of thousands have been forever > damaged because of it. > > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ > And that is the Landmark Significance of the Ruling on April 14, > 2006, Sacramento, California, regarding " Risk from inhaled mycotoxins in indoor > office and residential environments. Int J Toxicol 2004; 23: 3- 10.Robbins CA, > Swenson LJ, Hardin BD. (Veritox, 2004). The courts have found Veritox 2004 is > not plausible, improbable and Junk Science. > > Needless to say, I am thrilled. Maybe NOW we can get this issue out of the > courts and into doctors’ offices where it belongs. Maybe NOW we can all stop > wasting time, lives and money! > > Sharon Kramer > 760-822-8026 > > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.